Investors in West Pharmaceutical Services (NYSE:WST) Have Seen Strong Returns of 107% Over the Past Five Years
West Pharmaceutical Services Insider Sold Shares Worth $308,700, According to a Recent SEC Filing
Should You Hold West Pharmaceutical Services (WST) for the Long Term?
West Pharmaceutical Services (NYSE:WST) Jumps 4.4% This Week, Though Earnings Growth Is Still Tracking Behind Five-year Shareholder Returns
S&P 500, Nasdaq 100 Mark Seventh Straight Positive Session, Strongest Week Since October 2023: Friday's Top Movers
Unusual Options Activity: TXN, WST and Others Attract Market Bets, TXN V/OI Ratio Reaches 102.0
West Pharmaceutical Services Insider Sold Shares Worth $9,364,409, According to a Recent SEC Filing
Form 144 | West Pharmaceutical Services(WST.US) Officer Proposes to Sell 9.36 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Aug 6, $West Pharmaceutical Services(WST.US)$ Officer Green Eric Mark intends to sell 30,732 shares of its common stock on Aug 6, with a total market value of approximately $9.
42 High-quality, Low Beta Stocks to Better 'Sleep at Night' - BofA
West Pharmaceutical Services, Inc.'s (NYSE:WST) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
West Pharmaceutical Services To Go Ex-Dividend On July 31st, 2024 With 0.2 USD Dividend Per Share
Jefferies Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Cuts Target Price to $345
Express News | West Pharmaceutical Services Inc : Jefferies Cuts Target Price to $345 From $426
Ford, Stellantis And Dell Are Among Top 12 Large Cap Losers Last Week (July 21-July 27): Are The Others In Your Portfolio?
West Pharmaceutical Services, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
West Pharmaceutical Services Second Quarter 2024 Earnings: Misses Expectations
Express News | West Pharmaceutical Services Inc : UBS Cuts Target Price to $310 From $390
Stephens Adjusts Price Target on West Pharmaceutical Services to $340 From $400
Hold Rating on West Pharmaceutical Services Amid Forecast Challenges and Demand Slowdown
West Pharmaceutical Services | 10-Q: Q2 2024 Earnings Report